GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » SciBase Holding AB (OSTO:SCIB) » Definitions » 3-Year EPS without NRI Growth Rate

SciBase Holding AB (OSTO:SCIB) 3-Year EPS without NRI Growth Rate : 22.30% (As of Mar. 2024)


View and export this data going back to 2015. Start your Free Trial

What is SciBase Holding AB 3-Year EPS without NRI Growth Rate?

SciBase Holding AB's EPS without NRI for the three months ended in Mar. 2024 was kr-0.09.

During the past 3 years, the average EPS without NRI Growth Rate was 22.30% per year. During the past 5 years, the average EPS without NRI Growth Rate was 25.20% per year. During the past 10 years, the average EPS without NRI Growth Rate was 24.20% per year. Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the average EPS without NRI growth rate.

During the past 11 years, the highest 3-Year average EPS without NRI Growth Rate of SciBase Holding AB was 35.80% per year. The lowest was 13.30% per year. And the median was 24.60% per year.


Competitive Comparison of SciBase Holding AB's 3-Year EPS without NRI Growth Rate

For the Medical Devices subindustry, SciBase Holding AB's 3-Year EPS without NRI Growth Rate, along with its competitors' market caps and 3-Year EPS without NRI Growth Rate data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


SciBase Holding AB's 3-Year EPS without NRI Growth Rate Distribution in the Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, SciBase Holding AB's 3-Year EPS without NRI Growth Rate distribution charts can be found below:

* The bar in red indicates where SciBase Holding AB's 3-Year EPS without NRI Growth Rate falls into.



SciBase Holding AB 3-Year EPS without NRI Growth Rate Calculation

This is the 3-year average growth rate of EPS without NRI. The growth rate is calculated using exponential compounding based on the latest four year annual data.

Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the average EPS without NRI growth rate.


SciBase Holding AB  (OSTO:SCIB) 3-Year EPS without NRI Growth Rate Explanation

EPS without NRI is the amount of earnings without non-recurring items per outstanding share of the company's stock.

Earnings Per Share (EPS) is the single most important variable used by Wall Street in determining the earnings power of a company. But investors need to be aware that Earnings per Share can be easily manipulated by adjusting depreciation and amortization rate or non-recurring items. That's why GuruFocus lists Earnings per share without Non-Recurring Items, which better reflects the company's underlying performance.


SciBase Holding AB 3-Year EPS without NRI Growth Rate Related Terms

Thank you for viewing the detailed overview of SciBase Holding AB's 3-Year EPS without NRI Growth Rate provided by GuruFocus.com. Please click on the following links to see related term pages.


SciBase Holding AB (OSTO:SCIB) Business Description

Traded in Other Exchanges
Address
Landsvagen 39, Sundbyberg, Stockholm, SWE, 172 63
SciBase Holding AB is a medical technology company that develops devices for the evaluation of skin disorders such as skin cancer and atopic dermatitis. SciBase's products include Nevisense and Nevisense Go and to date, the platform addresses the areas of melanoma detection, non-melanoma skin cancer detection, and skin barrier assessment. It is the only FDA-approved device for the detection of melanoma and the only MDR-approved technology for skin cancer detection in Europe. The company operates in two segments: skin cancer and skin barrier assessment. Its geographical segments are Europe/Rest of the World, the United States/North America, and Asia/Oceania.

SciBase Holding AB (OSTO:SCIB) Headlines

No Headlines